The Pharmacogenomics Global Research Network Implementation Working Group: global collaboration to advance pharmacogenetic implementation.

Autor: Cavallari LH; Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, University of Florida, Gainesville., Hicks JK; Department of Pathology, Moffitt Cancer Center, Tampa, Florida., Patel JN; Atrium Health Levine Cancer Institute, Charlotte.; Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina., Elchynski AL; Department of Pharmacy, Arkansas Children's Hospital, Little Rock, Arkansas., Smith DM; MedStar Health, Columbia, Maryland.; Department of Oncology, Georgetown University Medical Center, Washington, DC., Bargal SA; Department of Medicine and Program for Personalized and Genomic Medicine, University of Maryland School of Medicine, Baltimore, Maryland., Fleck A; Department of Pharmacy, Richard L. Roudebush Veterans Affairs Medical Center, Veteran Health Indiana, Indianapolis, Indiana., Aquilante CL; Department of Pharmaceutical Sciences, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado.; Colorado Center for Personalized Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado., Killam SR; L.S. Skaggs Institute for Health Innovation and Department of Biomedical and Pharmaceutical Sciences, University of Montana, Missoula, Montana., Lemke L; Lifespan, Providence, Rhode Island, USA., Ochi T; Department of Pharmacotherapy, Epidemiology & Economics, Groningen Research Institute of Pharmacy; and University Library, University of Groningen, Groningen, The Netherlands., Ramsey LB; Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy Kansas City, Kansas City, Missouri., Haidar CE; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee., Ho T; Department of Pathology, Moffitt Cancer Center, Tampa, Florida., El Rouby N; Department of Pharmacy, St. Elizabeth HealthCare, Edgewood, Kentucky.; Division of Pharmacy Practice and Administrative Sciences, James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, Ohio., Monte AA; Rocky Mountain Poison & Drug Safety, Denver Health & Hospital Authority, Denver, Colorado.; University of Colorado School of Medicine, Aurora, Colorado., Allen JD; Department of Pharmacy, St. Elizabeth HealthCare, Edgewood, Kentucky., Beitelshees AL; Department of Medicine and Program for Personalized and Genomic Medicine, University of Maryland School of Medicine, Baltimore, Maryland., Bishop JR; Department of Experimental and Clinical Pharmacology and Department of Psychiatry and Behavioral Sciences, University of Minnesota, Minneapolis, Minnesota, USA., Bousman C; Department of Medical Genetics, University of Calgary, Calgary, Alberta, Canada., Campbell R; Allegheny General Hospital, Allegheny Health Network, Pittsburgh, Pennsylvania., Cicali EJ; Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, University of Florida, Gainesville., Cook KJ; Department of Pharmacy Education and Practice, University of Florida College of Pharmacy.; Nemours Children's Health, Jacksonville, Florida., Duong B; Precision Medicine Program, Nemours Children's Health Delaware Valley, Wilmington, Delaware, USA., Tsermpini EE; Pharmacogenetics Laboratory, Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia., Girdwood ST; Divisions of Hospital Medicine and Translational and Clinical Pharmacology, Cincinnati Children's Hospital.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio., Gregornik DB; Pharmacogenomics Program, Children's Minnesota, Minneapolis/St Paul, Minnesota., Grimsrud KN; Department of Pathology and Laboratory Medicine, University of California Health, Sacramento, California., Lamb N; Department of Pharmacy, Ann & Robert H. Lurie Children's Hospital of Chicago., Lee JC; Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, Illinois, USA., Lopez RO; Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Monterrey, Nuevo León, Mexico., Mazhindu TA; African Institute of Biomedical Sciences & Technology, Harare, Zimbabwe., Morris SA; Atrium Health Levine Cancer Institute, Charlotte.; Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina., Nagy M; Personalised Medication Management Unit, Children's Cancer Hospital Egypt 57357, Cairo, Egypt., Nguyen J; Personalized Care Program, Children's Hospital Los Angeles, Los Angeles, California., Pasternak AL; Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, Michigan., Petry N; Sanford Imagenetics, Sanford Health, Sioux Falls, South Dakota.; Department of Pharmacy Practice, North Dakota State University, Fargo, North Dakota, USA., van Schaik RHN; Department of Clinical Chemistry, Erasmus MC University Medical Center, Rotterdam, The Netherlands., Schultz A; Sanford Imagenetics, Sanford Health, Sioux Falls, South Dakota.; Department of Internal Medicine, University of South Dakota School of Medicine, Vermillion, South Dakota., Skaar TC; Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, Indiana, USA., Al Alshaykh H; Pharmaceutical Care Department, King Faisal Specialist Hospital and Research Center, College of Pharmacy, Alfaisal University, Riyadh, Saudi Arabia., Stevenson JM; Division of Clinical Pharmacology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland., Stone RM; Department of Pharmacy, University of Virginia, Charlottesville, Virginia., Tran NK; Department of Pathology and Laboratory Medicine, University of California Health, Sacramento, California., Tuteja S; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Woodahl EL; L.S. Skaggs Institute for Health Innovation and Department of Biomedical and Pharmaceutical Sciences, University of Montana, Missoula, Montana., Yuan LC; Providence Health and Services, Irvine, California., Lee CR; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Publikováno v: Pharmacogenetics and genomics [Pharmacogenet Genomics] 2025 Jan 01; Vol. 35 (1), pp. 1-11. Date of Electronic Publication: 2024 Oct 03.

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of CYP2C9, HLA-A and HLA-B with anti-epileptic drugs.

Autor: Manson LEN; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands., Nijenhuis M; Royal Dutch Pharmacists Association (KNMP), The Hague, The Netherlands. M.Nijenhuis@knmp.nl., Soree B; Royal Dutch Pharmacists Association (KNMP), The Hague, The Netherlands., de Boer-Veger NJ; Pharmacy Boterdiep, Groningen, The Netherlands., Buunk AM; Pharmacy De Katwijkse Apotheek, Katwijk, The Netherlands., Houwink EJF; Department of Family Medicine, Mayo Clinic, Rochester, MN, USA., Risselada A; Department of Clinical Pharmacy, Wilhelmina Hospital, Assen, The Netherlands., Rongen GAPJM; Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Pharmacology and Toxicology, Radboud University Medical Center, Nijmegen, The Netherlands., van Schaik RHN; Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands., Swen JJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands., Touw DJ; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Department of Pharmaceutical Analysis, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands., van Westrhenen R; Department of Psychiatry, Parnassia Group, Amsterdam, The Netherlands.; Department of Psychiatry and Neuropsychology, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.; Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King's College London, London, UK., Deneer VHM; Department of Clinical Pharmacy, Division Laboratories, Pharmacy and Biomedical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.

Publikováno v: European journal of human genetics : EJHG [Eur J Hum Genet] 2024 Aug; Vol. 32 (8), pp. 903-911. Date of Electronic Publication: 2024 Apr 03.

First-trimester maternal tryptophan metabolites, utero-placental (vascular)development and hypertensive disorders of pregnancy: The Rotterdam periconceptional cohort.

Autor: van Zundert SKM; Department of Obstetrics and Gynaecology, Erasmus MC, University Medical Centre Rotterdam, the Netherlands; Department of Clinical Chemistry, Erasmus MC, University Medical Centre Rotterdam, the Netherlands., Broekhuizen M; Division of Neonatology, Department of Neonatal and Pediatric Intensive Care, Erasmus MC, University Medical Centre Rotterdam, the Netherlands; Division of Pharmacology and Vascular Medicine, Department of Internal Medicine, Erasmus MC, University Medical Centre Rotterdam, the Netherlands., Mirzaian M; Department of Clinical Chemistry, Erasmus MC, University Medical Centre Rotterdam, the Netherlands., van Rossem L; Department of Obstetrics and Gynaecology, Erasmus MC, University Medical Centre Rotterdam, the Netherlands., Danser AHJ; Division of Pharmacology and Vascular Medicine, Department of Internal Medicine, Erasmus MC, University Medical Centre Rotterdam, the Netherlands., Willemsen SP; Department of Obstetrics and Gynaecology, Erasmus MC, University Medical Centre Rotterdam, the Netherlands; Department of Biostatistics, Erasmus MC, University Medical Centre Rotterdam, the Netherlands., Griffioen PH; Department of Clinical Chemistry, Erasmus MC, University Medical Centre Rotterdam, the Netherlands., Koning AHJ; Department of Pathology, Erasmus MC, University Medical Centre Rotterdam, the Netherlands., Mulders AGMGJ; Department of Obstetrics and Gynaecology, Erasmus MC, University Medical Centre Rotterdam, the Netherlands., van Schaik RHN; Department of Clinical Chemistry, Erasmus MC, University Medical Centre Rotterdam, the Netherlands., Steegers-Theunissen RPM; Department of Obstetrics and Gynaecology, Erasmus MC, University Medical Centre Rotterdam, the Netherlands. Electronic address: r.steegers@erasmusmc.nl.

Publikováno v: Placenta [Placenta] 2024 Dec; Vol. 158, pp. 105-112. Date of Electronic Publication: 2024 Oct 15.

Cost-effectiveness of Implementing a Genotype-Guided De-Escalation Strategy in Patients with Acute Coronary Syndrome.

Autor: van den Broek WWA; Department of Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands., Azzahhafi J; Department of Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands., Chan Pin Yin DRPP; Department of Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands., van der Sangen NMR; Department of Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands., Sivanesan S; Department of Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands., Dijksman LM; Department of Value-Based Healthcare, St. Antonius Hospital, Nieuwegein, The Netherlands., Walhout RJ; Department of Cardiology, Hospital Gelderse Vallei, Ede, The Netherlands., Gin MTJ; Department of Cardiology, Rijnstate Hospital, Arnhem, The Netherlands., Breet NJ; Department of Cardiology, Gelre Hospitals, Apeldoorn, The Netherlands., Langerveld J; Department of Cardiology, Rivierenland Hospital, Tiel, The Netherlands., Vlachojannis GJ; Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands., van Bommel RJ; Department of Cardiology, Tergooi Hospital, Hilversum, The Netherlands., Appelman Y; Department of Cardiology, Amsterdam UMC, VU University, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands., van Schaik RHN; Department of Clinical Chemistry, Erasmus MC - University Medical Center, Rotterdam, The Netherlands., Henriques JPS; Department of Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands., Kikkert WJ; Department of Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.; Department of Cardiology, Tergooi Hospital, Hilversum, The Netherlands., Ten Berg JM; Department of Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands.; Cardiovascular Research Institute Maastricht, University Medical Center Maastricht, Maastricht, The Netherlands.

Publikováno v: European heart journal. Cardiovascular pharmacotherapy [Eur Heart J Cardiovasc Pharmacother] 2024 Nov 13. Date of Electronic Publication: 2024 Nov 13.

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP2C19 and non-SSRI/non-TCA antidepressants.

Autor: Beunk L; Department of Clinical Chemistry, St Jansdal Hospital, Harderwijk, The Netherlands., Nijenhuis M; Royal Dutch Pharmacists Association (KNMP), The Hague, The Netherlands. M.Nijenhuis@knmp.nl., Soree B; Royal Dutch Pharmacists Association (KNMP), The Hague, The Netherlands., de Boer-Veger NJ; Pharmacy Boterdiep, Groningen, The Netherlands., Buunk AM; Pharmacy De Katwijkse Apotheek, Katwijk, The Netherlands., Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands., Houwink EJF; Department of Family Medicine, Mayo Clinic, Rochester, MN, USA., Risselada A; Department of Clinical Pharmacy, Wilhelmina Hospital, Assen, The Netherlands., Rongen GAPJM; Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Pharmacology and Toxicology, Radboud University Medical Center, Nijmegen, The Netherlands., van Schaik RHN; Department of Clinical Chemistry, Erasmus MC University Medical Center, Rotterdam, The Netherlands., Swen JJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands., Touw D; Department of Pharmaceutical Analysis, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands.; Department of Clinical Pharmacy & Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Deneer VHM; Department of Clinical Pharmacy, Division Laboratories, Pharmacy and Biomedical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., van Westrhenen R; Department of Psychiatry, Parnassia Group, Amsterdam, Netherlands.; Institute of Psychiatry, Psychology&Neuroscience (IoPPN), King's College London, London, UK.; St. John's National Academy of health Sciences, Bangalore, India.

Publikováno v: European journal of human genetics : EJHG [Eur J Hum Genet] 2024 Nov; Vol. 32 (11), pp. 1371-1377. Date of Electronic Publication: 2024 Jul 02.